Peptide Cancer Vaccine Market Global Insights Marshawn Lynch Youth Jersey , 2018-2026 Health Articles | July 15, 2018
Increasing prevalence of cancer and failure of conventional methods to treat the disease effectively have led to increasing demand for new immunotherapy-based therapy such as peptide vaccine.
Peptide cancer vaccines aids to elicit and expand tumor-specific T-cells capable of controlling or eradicating tumor. This vaccine consists of one or more short or long amino acid sequences as tumor antigens, combined with vaccine adjuvant. In the recent past, results of clinical trials performed using peptide cancer vaccine had exhibited negative outcomes. So, researchers in the peptide vaccine have considered this as outdated therapy and declared it as no longer viable for cancer treatment. However, increasing progress in understanding critical role of immune adjuvants, modes of vaccine administration, and T cell dynamics has led to re-emergence of this approach for treating malignant disorders.